サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1390791

超崩壊剤市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測

Superdisintegrants Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 140 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.86円
超崩壊剤市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測
出版日: 2023年11月24日
発行: IMARC
ページ情報: 英文 140 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

概要

世界の超崩壊剤の市場規模は2022年に3億8,880万米ドルに達しました。今後、IMARC Groupは、市場は2028年までに5億9,010万米ドルに達し、2022年から2028年の間に7.20%の成長率（CAGR）を示すと予測しています。

超崩壊剤は、錠剤やカプセルの小さな粒子への分解や崩壊を促進するために医薬品製剤に添加される改良型崩壊剤です。薬剤の吸収を促進し、体内での医薬品有効成分（API）の溶解度を高めることにより、崩壊時間を短縮し、経口固形製剤の効率を高める。これらは固形剤形中では低レベルで利用され、一般的には剤形の総重量に対して1～10重量％です。現在、超崩壊剤は合成品と天然品があり、心血管疾患、感染症、血液疾患、神経疾患、消化器疾患、炎症性疾患など多くの治療分野で使用されています。

超崩壊剤の市場動向：

現在、医薬品業界では固形剤が大きなシェアを占めています。これは、様々な加齢関連疾患や慢性疾患を患う人々の増加と相まって、市場の成長を強化する重要な要因の一つとなっています。さらに、抗精神病薬、抗うつ薬、抗偏頭痛薬、鎮静薬などの口腔内崩壊錠（ODT）の製造における超崩壊剤の広範な使用は、業界の投資家に有利な成長機会を提供しています。これとは別に、高い適合性、バイオアベイラビリティの向上、効率的な圧縮性といった特徴が、世界の超崩壊剤の需要を喚起しています。さらに、大手企業は市場での競争力を維持するため、製品開拓や新規製剤のイノベーションに多大な投資を行っています。これに加えて、厳しい規制が製薬業界におけるより安全な代替品の使用を後押ししており、天然型過分解薬が世界中で広く受け入れられています。さらに、コロナウイルス感染症（COVID-19）の流行による遠隔医療の人気の高まりと相まって、神経障害の負担が増加していることも、市場の成長を後押しすると予想されています。

本レポートで扱う主な質問

  • 世界の超崩壊剤市場はこれまでどのように推移し、今後数年間はどのように推移するのか？
  • COVID-19が世界の超崩壊剤市場に与えた影響は？
  • 主要な地域市場は？
  • 製品別の市場内訳は？
  • タイプ別の市場内訳は？
  • 剤形別の市場内訳は？
  • 治療領域別の市場内訳は？
  • 業界のバリューチェーンにおける様々な段階とは？
  • 業界の主要な促進要因と課題は何か？
  • 世界の超崩壊剤市場の構造と主要プレーヤーは？
  • 業界における競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 超崩壊剤の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • クロスカルメロースナトリウム
    • 市場動向
    • 市場予測
  • クロスポビドン
    • 市場動向
    • 市場予測
  • デンプングリコール酸ナトリウム
    • 市場動向
    • 市場予測
  • イオン交換樹脂
    • 市場動向
    • 市場予測
  • 変性セルロース
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 市場内訳：タイプ別

  • 天然系超崩壊剤
    • 市場動向
    • 市場予測
  • 合成高崩壊剤
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：剤形別

  • 錠剤・カプセル剤
    • 市場動向
    • 市場予測
  • 口中溶解フィルム
    • 市場動向
    • 市場予測

第9章 市場内訳：治療領域別

  • 消化器
    • 市場動向
    • 市場予測
  • 循環器
    • 市場動向
    • 市場予測
  • 神経内科
    • 市場動向
    • 市場予測
  • 腫瘍学
    • 市場動向
    • 市場予測
  • ヘマトロジー
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Asahi Kasei Corporation
    • Ashland Global Specialty Chemicals Inc.
    • Avantor Inc.
    • BASF SE
    • Corel Pharma Chem
    • DFE Pharma GmbH & Co. KG
    • DuPont de Nemours Inc.
    • JRS Pharma GmbH & Co. KG
    • Merck KGaA
    • Nippon Soda Co. Ltd.
    • Roquette Freres
    • Sigachi Industries Limited
図表

List of Figures

  • Figure 1: Global: Superdisintegrants Market: Major Drivers and Challenges
  • Figure 2: Global: Superdisintegrants Market: Sales Value (in Million US$), 2017-2022
  • Figure 3: Global: Superdisintegrants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 4: Global: Superdisintegrants Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Superdisintegrants Market: Breakup by Type (in %), 2022
  • Figure 6: Global: Superdisintegrants Market: Breakup by Dosage Form (in %), 2022
  • Figure 7: Global: Superdisintegrants Market: Breakup by Therapeutic Areas (in %), 2022
  • Figure 8: Global: Superdisintegrants Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Superdisintegrants (Croscarmellose Sodium) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Superdisintegrants (Croscarmellose Sodium) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Superdisintegrants (Crospovidone) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Superdisintegrants (Crospovidone) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Superdisintegrants (Sodium Starch Glycolate) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Superdisintegrants (Sodium Starch Glycolate) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Superdisintegrants (Ion Exchange Resin) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Superdisintegrants (Ion Exchange Resin) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Superdisintegrants (Modified Cellulose) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Superdisintegrants (Modified Cellulose) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Superdisintegrants (Other Products) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Superdisintegrants (Other Products) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Superdisintegrants (Natural Superdisintegrant) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Superdisintegrants (Natural Superdisintegrant) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Superdisintegrants (Synthetic Superdisintegrant) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Superdisintegrants (Synthetic Superdisintegrant) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Superdisintegrants (Other Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Superdisintegrants (Other Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Superdisintegrants (Tablets and Capsules) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Superdisintegrants (Tablets and Capsules) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Superdisintegrants (Mouth-Dissolving Films) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Superdisintegrants (Mouth-Dissolving Films) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Superdisintegrants (Gastrointestinal) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Superdisintegrants (Gastrointestinal) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Superdisintegrants (Cardiovascular) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Superdisintegrants (Cardiovascular) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Superdisintegrants (Neurology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Superdisintegrants (Neurology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Superdisintegrants (Oncology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Superdisintegrants (Oncology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Global: Superdisintegrants (Hematology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Global: Superdisintegrants (Hematology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Global: Superdisintegrants (Other Therapeutic Areas) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Global: Superdisintegrants (Other Therapeutic Areas) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: North America: Superdisintegrants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: North America: Superdisintegrants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: United States: Superdisintegrants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: United States: Superdisintegrants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Canada: Superdisintegrants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Canada: Superdisintegrants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Asia-Pacific: Superdisintegrants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Asia-Pacific: Superdisintegrants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: China: Superdisintegrants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: China: Superdisintegrants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Japan: Superdisintegrants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Japan: Superdisintegrants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: India: Superdisintegrants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: India: Superdisintegrants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: South Korea: Superdisintegrants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: South Korea: Superdisintegrants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Australia: Superdisintegrants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Australia: Superdisintegrants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Indonesia: Superdisintegrants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Indonesia: Superdisintegrants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Others: Superdisintegrants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Others: Superdisintegrants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Europe: Superdisintegrants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Europe: Superdisintegrants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Germany: Superdisintegrants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Germany: Superdisintegrants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: France: Superdisintegrants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: France: Superdisintegrants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: United Kingdom: Superdisintegrants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: United Kingdom: Superdisintegrants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Italy: Superdisintegrants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Italy: Superdisintegrants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Spain: Superdisintegrants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Spain: Superdisintegrants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Russia: Superdisintegrants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Russia: Superdisintegrants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Others: Superdisintegrants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Others: Superdisintegrants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Latin America: Superdisintegrants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Latin America: Superdisintegrants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Brazil: Superdisintegrants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Brazil: Superdisintegrants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Mexico: Superdisintegrants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Mexico: Superdisintegrants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 87: Others: Superdisintegrants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 88: Others: Superdisintegrants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 89: Middle East and Africa: Superdisintegrants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 90: Middle East and Africa: Superdisintegrants Market: Breakup by Country (in %), 2022
  • Figure 91: Middle East and Africa: Superdisintegrants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 92: Global: Superdisintegrants Industry: SWOT Analysis
  • Figure 93: Global: Superdisintegrants Industry: Value Chain Analysis
  • Figure 94: Global: Superdisintegrants Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Superdisintegrants Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Superdisintegrants Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Superdisintegrants Market Forecast: Breakup by Type (in Million US$), 2023-2028
  • Table 4: Global: Superdisintegrants Market Forecast: Breakup by Dosage Form (in Million US$), 2023-2028
  • Table 5: Global: Superdisintegrants Market Forecast: Breakup by Therapeutic Areas (in Million US$), 2023-2028
  • Table 6: Global: Superdisintegrants Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Superdisintegrants Market: Competitive Structure
  • Table 8: Global: Superdisintegrants Market: Key Players
目次
Product Code: SR112023A4641

Abstract

The global superdisintegrants market size reached US$ 388.8 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 590.1 Million by 2028, exhibiting a growth rate (CAGR) of 7.20% during 2022-2028.

Superdisintegrants are modified disintegrants added in drug formulations to facilitate the breakup or disintegration of tablets or capsules into smaller particles. They assist in increasing the absorption of the drug and the solubility of active pharmaceutical ingredients (APIs) in the body, thereby reducing the disintegration time or oral solid dosage forms and enhancing their efficiency. They are utilized at a low level in the solid dosage form, generally 1- 10% by weight relative to the total weight of the dosage unit. Presently, they are available in synthetic and natural variants and used in many therapeutic areas, such as cardiovascular, infectious, hematological, neurological, gastrointestinal diseases, and inflammatory diseases.

Superdisintegrants Market Trends:

Solid dosage medicines currently hold a significant share in the pharmaceutical industry. This, coupled with the rising number of people suffering from various age-related and chronic diseases, represents one of the key factors strengthening the growth of the market. Moreover, the extensive usage of superdisintegrants in the production of orally disintegrating tablets (ODTs) for antipsychotics, antidepressants, antimigraine, and sedatives is offering lucrative growth opportunities to industry investors. Apart from this, features like high compatibility, improved bioavailability, and efficient compressibility are catalyzing the demand for superdisintegrants worldwide. Additionally, leading players are considerably investing in product development and innovation of novel formulations to retain a competitive edge in the market. Besides this, stringent regulations are propelling the use of safer alternatives in the pharmaceutical industry, which is assisting in the wider acceptance of natural superdisintegrants around the world. Furthermore, the growing burden of neurological disorders, in confluence with the increasing popularity of telemedicine on account of the coronavirus disease (COVID-19) outbreak, is anticipated to impel the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global superdisintegrants market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, type, dosage form and therapeutic areas.

Breakup by Product:

Croscarmellose Sodium

Crospovidone

Sodium Starch Glycolate

Ion Exchange Resin

Modified Cellulose

Others

Breakup by Type:

Natural Superdisintegrant

Synthetic Superdisintegrant

Others

Breakup by Dosage Form:

Tablets and Capsules

Mouth-Dissolving Films

Breakup by Therapeutic Areas:

Gastrointestinal

Cardiovascular

Neurology

Oncology

Hematology

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Asahi Kasei Corporation, Ashland Global Specialty Chemicals Inc., Avantor Inc., BASF SE, Corel Pharma Chem, DFE Pharma GmbH & Co. KG, DuPont de Nemours Inc., JRS Pharma GmbH & Co. KG, Merck KGaA, Nippon Soda Co. Ltd., Roquette Freres and Sigachi Industries Limited.

Key Questions Answered in This Report:

  • How has the global superdisintegrants market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global superdisintegrants market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the dosage form?
  • What is the breakup of the market based on the therapeutic areas?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global superdisintegrants market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Superdisintegrants Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Croscarmellose Sodium
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Crospovidone
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Sodium Starch Glycolate
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Ion Exchange Resin
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Modified Cellulose
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Type

  • 7.1 Natural Superdisintegrant
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Synthetic Superdisintegrant
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Dosage Form

  • 8.1 Tablets and Capsules
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Mouth-Dissolving Films
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Therapeutic Areas

  • 9.1 Gastrointestinal
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Cardiovascular
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Neurology
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Oncology
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Hematology
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast
  • 9.6 Others
    • 9.6.1 Market Trends
    • 9.6.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Asahi Kasei Corporation
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Ashland Global Specialty Chemicals Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Avantor Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
    • 15.3.4 BASF SE
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Corel Pharma Chem
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 DFE Pharma GmbH & Co. KG
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 DuPont de Nemours Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 JRS Pharma GmbH & Co. KG
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Merck KGaA
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Nippon Soda Co. Ltd.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Roquette Freres
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 SWOT Analysis
    • 15.3.12 Sigachi Industries Limited
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio